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Abstract
Scope—n-3 polyunsaturated fatty acid (n-3 PUFA) intake is associated with protection from 
obesity, however, the mechanisms of protection remain poorly characterized. The stearoyl CoA 
desaturase (SCD), insulin sensitive glucose transporter (SLC2A4), and sterol regulatory element 
binding protein (SREBF1) genes are transcriptionally regulated by n-3 PUFA intake and harbor 
polymorphisms associated with obesity. The present study investigated how consumption of n-3 
PUFA modifies associations between SCD, SLC2A4, and SREBF1 polymorphisms and 
anthropometric variables and metabolic phenotypes.
Materials and Methods—Anthropometric variables and metabolic phenotypes were measured 
in a cross-sectional sample of Yup’ik individuals (n=1135) and thirty-three polymorphisms were 
tested for main effects and interactions using linear models that account for familial correlations. 
n-3 PUFA intake was estimated using red blood cell nitrogen stable isotope ratios. SCD 
polymorphisms were associated with ApoA1 concentration and n-3 PUFA interactions with SCD 
polymorphisms were associated with reduced fasting cholesterol levels and waist-to-hip ratio. 
SLC2A4 polymorphisms were associated with hip circumference, high-density lipoprotein and 
ApoA1 concentrations. SREBF1 polymorphisms were associated with low-density lipoprotein and 
HOMA-IR and n-3 PUFA interactions were associated with reduced fasting insulin and HOMA-IR 
levels.
Conclusion—These results suggest that an individual’s genotype may interact with dietary n-3 
PUFAs in ways that are associated with protection from obesity-related diseases in Yup’ik people.
Keywords
δ15N; BMI; Alaska Native; gene-by-environment interactions; rs11190480; rs2167444; rs5415; 
rs5435; CANHR; n-3 PUFA
1 INTRODUCTION
Accumulation of excess body fat increases the risk of developing type-2 diabetes mellitus 
(T2DM) and cardiovascular disease (CVD) [1]. However, there are subgroups of “healthy 
obese” individuals that appear to carry excess body fat without developing adverse sequelae 
[2, 3]. Current understanding of the interplay of genetic and environmental factors in the 
“healthy obese” phenotypes remains limited despite its potential to offer valuable 
mechanistic insights into obesity-related diseases.
Consumption of n-3 PUFAs, namely eicosapentaenoic (EPA) and docosahexaenoic acids 
(DHA), is associated with phenotypes consistent with “healthy obesity,” including reduced 
incidence of diabetes [4], reduced adiposity [5], and improvement in fasting lipids [6]. 
Among Yup’ik people living in Southwest Alaska, we have previously reported that a 
traditional Yup’ik diet is enriched with EPA and DHA and associated with lower triglyceride 
levels [7, 8], reduced C-reactive protein levels [9], elevated HDL-cholesterol levels [7], 
reduced blood pressure, and elevated adiponectin levels, suggestive of increased insulin 
sensitivity [8]. Importantly, the average BMI (28.0 kg/m2) in this Yup’ik study population is 
similar to the average BMI (27.0 kg/m2) in the National Health and Nutritional Examination 
(NHANES) III survey [10]; however, the prevalence of T2DM in Yup’ik people is 
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considerably lower (3-4%) [11, 12] than the general U.S. population (8.3%) [13]. Given the 
chronic high intake of n-3 PUFA observed among mostly older Yup’ik people (20 times 
greater than the current mean intake of the general US population [14, 15]) accumulating 
evidence suggests that n-3 PUFA intake may be a critical environmental exposure that 
contributes to the “healthy obesity” phenotype observed in Yup’ik people.
The mechanisms underlying the protective effects of n-3 PUFAs on obesity and 
cardiometabolic health include, among others, changes in expression of stearoyl CoA 
desaturase (SCD) [16, 17], transcription factor sterol regulatory element binding protein 
(SREBF1) [18] , and insulin sensitive glucose transporter (SLC2A4, also commonly 
referenced as GLUT4 [19]. SCD is the rate-controlling enzyme catalyzing the biosynthesis 
of monounsaturated fatty acids (MUFAs) from saturated fatty acid substrates [20]. In mice, 
Scd1 (mouse SCD homolog) deficiency was associated with increased energy expenditure 
[21], reduced adiposity [22], increased insulin sensitivity [23], protection against 
hypertriglyceridemia [24], and with elevated HDL-cholesterol levels [24]. On the other 
hand, the gene product of SLC2A4 is the rate-limiting step in skeletal muscle glucose uptake 
[25] and targeted disruption of Slc2a4 in mice- through selective knockout in muscle tissue- 
results in severe insulin resistance and glucose intolerance from an early age [26]. Finally, 
SREBF1 is a transcription factor that plays a critical role in energy homeostasis by 
promoting glycolysis, lipogenesis, and adipogenesis [27]. Srebf1 over-expression in animal 
models results in insulin resistance through over-accumulation of lipid/lipoprotein substrates 
[28].
Whole-genome linkage studies in humans have implicated SCD, SLC2A4, and SREBF1 as 
obesity candidate genes [29–31] and genetic polymorphisms in these genes have been 
associated with metabolic syndrome [32], obesity [33, 34], T2DM [35, 36], and cholesterol 
metabolism [37–39]. Moreover, a clinical trial demonstrated that the effects of dietary n-3 
PUFA supplementation on cardiometabolic health may vary by SCD [40] as well as 
SREBF1 genotype [41]. Taken together, we hypothesize that genetic variation in SCD, 
SLC2A4, and SREBF1 may partially explain the association between n-3 PUFA intake and 
“healthy obesity” observed in Yup’ik people. Therefore, the aim of the present study was to 
test genetic polymorphisms in SCD, SLC2A4 and SREBF1 for association with 
anthropometric variables, T2DM, and fasting lipid phenotypes in a study population of 
Yup’ik people and evaluate whether these associations are modified by a traditional diet 
enriched with n-3 PUFAs.
2 MATERIALS ANDMETHODS
2.1 PARTICIPANTS AND METHODS
Recruitment of Yup’ik participants was initiated in 2003 and continues in 11 Southwest 
Alaska communities. Participants signed informed-consent documents before entering the 
study using protocols that were approved by the University of Alaska Institutional Review 
Board, the National and Alaska Area Indian Health Service Institutional Review Boards, and 
the Yukon-Kuskokwim Health Corporation Human Studies Committee. Data on familial 
relationships used in this study to generate pedigrees were obtained through self-report at the 
time participants were enrolled in the CANHR study. Summary statistics specific to 
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characteristics of the Yup’ik pedigree were calculated using PEDINFO in the Statistical 
Analysis for Genetic Epidemiology (S.A.G.E., 2009) software.
2.2 ANTHROPOMETRIC AND BIOCHEMICAL MEASUREMENT
Trained staff obtained height, weight and 4 circumferences (waist, hip, triceps, and thigh) 
measurements using protocols from the NHANES III Anthropometric Procedures Manual 
[42] as previously described [43]. Percent body fat (PBF) was measured by electrical 
bioimpedance using a Tanita TBF-300A body fat analyzer (Tanita Corp, Arlington Heights, 
IL, U.S.A.). Blood samples were collected from participants after an overnight fast, and 
lipoproteins including total cholesterol, HDL-, LDL-, and VLDL- cholesterol, 
apolipoprotein A1, and plasma triglycerides concentrations were assayed as previously 
described [43]. From blood samples, we also measured fasting insulin (FI), blood glucose 
(FG), glycosylated hemoglobin (HbA1c) and calculated HOMA-IR (homeostatic model 
assessment of insulin resistance) and HOMA-B (homeostatic model assessment of beta-cell 
function) as described previously [44]. Finally, we defined a continuous variable called ‘FG 
& HbA1c’ that is described in greater detail along with information on participant 
medications within the Supporting Information Methods S1.
2.3 BIOMARKER FOR MARINE n-3 PUFA INTAKE
n-3 PUFA intake was assessed using the nitrogen stable isotope ratio (δ15N) of red blood 
cells (RBC), which has been validated as a biomarker for EPA and DHA intake as 
previously described [45]. The time to 50% turnover of RBC is approximately 45 days [46], 
therefore, the mean RBC δ15N values reflect a mean n-3 PUFA intake over 1.5 months. 
Isotope ratios are analyzed relative to IAEA-certified reference materials calibrated to 
atmospheric nitrogen, for which 15N/14N = 0.0036765. By convention and for ease of 
interpretation, isotope ratios are presented as delta values in “permil” relative to atmospheric 
nitrogen: δ15N = [(15N/14Nsample – 15N/14Nstandard)/( 15N/14Nstandard)] · 1000‰. The 
range of isotopic variation in our dataset (9‰) was very large relative to analytical precision 
(within 0.2‰). We hereafter refer to the nitrogen stable isotope ratio of red blood cells 
(RBC) as δ15N.
2.4 SNP GENOTYPING
Our final genotyping list included 13 SNPs in SCD, 13 SNPs in SLC2A4, and 8 SNPs in 
SREBF1 that were genotyped using the Sequenom iPLEX platform at the Broad Institute 
[47]. Linkage disequilibrium (LD) among SNPs in each gene was calculated from haplotype 
frequencies estimated using the hapfreq command in the FBAT program [48]. We used pair-
wise r-squared (r2) as the metric of LD and limited presentation of haplotypes to those with 
>5% frequency. Information on SNP selection is presented in Supporting Information 
Methods S2 and a description of the primers for SNP 12 and SNP 13 in SLC2A4 is 
presented in Supporting Information Table 1.
2.5 ASSOCIATION ANALYSIS
Each SNP was tested for association with anthropometric variables, lipid/lipoprotein, and 
T2DM-related phenotypes using the program ASSOC [49] in the S.A.G.E software package. 
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Each SNP included in the analysis was coded as additive by default (defined as the number 
of minor alleles); however when fewer than 10% of the individuals genotyped for a given 
SNP were homozygous for the minor allele- we coded the SNPs as dominant (defined as two 
copies of the major allele compared to at least one copy of the minor allele). Likelihood ratio 
statistics were calculated to compare 3 nested models and test the null hypothesis of no 
association between SNPs and outcomes after adjusting for covariates.
Model 1 included baseline covariates (age, sex, community membership) and δ15N; Model 2 
included baseline covariates, δ15N, and SNP to test for main genetic effect; Model 3 
included baseline covariates, the genetic effect of SNPs, δ15N, and interactions between the 
genetic effect and δ15N. Note that model 3 is the only model to directly test gene-diet 
interactions under the null hypothesis between continuous δ15N and ordinal SNP genotypes. 
Additionally, lipid/lipoprotein and T2DM-related phenotypes included BMI and medication 
use as baseline covariates in Model 1, 2 and 3. We treated each phenotype being tested as 
representing a separate family of null hypotheses and correct for the number of tests within 
each family [50]. P-values were compared to the conventional significance threshold 
(p<0.05, 2-tailed), as well as significance thresholds adjusted for multiple test correction. 
Multiple test correction in this study was calculated according to the number of non-
redundant SNPs with MAF ≥0.05 for SCD (7 tests; α≤0.007), SLC2A4 (6 tests; α≤0.008), 
and SREBF1 (4 tests; α≤0.013) using spectral decomposition of LD matrices [51].
Estimates of effect size (β) were extracted from linear models adjusted for demographic and 
environmental covariates. Statistical power that accounted for familial correlations [51] was 
assessed using SAS version 9.1 (SAS Institute, Cary, NC). The general estimates of power in 
our sample using an additive genetic model at α = 0.005 for detecting the effect sizes (β) in 
transformed phenotypes (i.e. BMI) between 0.1 and 1.5 were >90% when the minor allele 
frequency was at least 5%. Additional information on data management, statistical analyses 
and multiple test correction can be found in Supporting Information Methods S3 and S4.
3 RESULTS
3.1 CHARACTERISTICS OF YUP’IK PARTICIPANTS
Our study population of 1135 non-pregnant Yup’ik participants represents 195 pedigrees 
with a mean pedigree size of 5.82 individuals (Table 1). In general, Yup’ik women had 
significantly greater levels of adiposity (BMI, PBF, and HC) and higher fasting total 
cholesterol, HDL-cholesterol and ApoA1 concentrations relative to Yup’ik men (p<0.0001). 
Additionally, Yup’ik women had significantly higher FI, HOMA-IR, and HOMA-B, and 
significantly lower waist-to-hip ratio and FG. Thirteen individuals reported taking T2DM-
related medication and 55 individuals reported taking lipid/lipoprotein medications.
3.2 DISTRIBUTION OF δ15N IN STUDY POPULATION
Summary statistics for δ15N, our biomarker of n-3 PUFA intake, are grouped by gender and 
reported in Table 2. The overall mean δ15N value in this study was 9.0‰, and ranged from 
6.2‰ to 15.2‰. According to the linear relationship between RBC δ15N and RBC EPA 
described elsewhere for this cohort [45], the corresponding mean EPA (%RBC fatty acids) 
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was 2.6%. The standard deviation of δ15N in this sample did not differ according to gender 
(1.5‰ for both females and males).
3.3 GENETIC VARIATION IN SCD, SLC2A4, AND SREBF1
A comprehensive list of thirty-four SNPs in SCD, SLC2A4 and SREBF1 were genotyped in 
1135 Yup’ik participants with a mean genotyping success rate of 93.2% (range 81.2-99.4%). 
The rs41290540 SNP in SCD (MAF=0.12) was the only polymorphism with MAF ≥0.05 
that deviated significantly from HWE proportions (p=0.0002) and was therefore excluded 
from the analysis. The genetic analyses in this study included the 23 SNPs with MAF ≥ 0.05 
that did not deviate from HWE proportions (Table 3). Two SNPs (rs11557927 and 2282180) 
in the analysis were coded as dominant. We have limited the presentation and discussion of 
the results below to those tests that were statistically significant; however, all tabular results 
for SNP association, gene-diet interactions, and pairwise linkage disequilibrium (LD) results 
are presented in Supporting Information Tables 2-8.
3.4 ANALYSIS OF LIPID/LIPOPROTEIN PHENOTYPES
Figure 1 presents associations between SNPs in SCD, SLC2A4, and SREBF1 with MAF 
≥0.05 and lipid/lipoprotein phenotypes. The solid red line represents statistical significance 
according to multiple test correction for each gene. Notably, rs2167444 and rs7849 in SCD 
were in weak LD (r2=0.11) and significantly associated with fasting plasma ApoA1 
concentrations. The rs5415 and rs5435 polymorphisms in SLC2A4 were in moderate LD 
(r2=0.48) and significantly associated with both fasting plasma ApoA1 concentrations and 
HDL-cholesterol. An SREBF1 SNP (rs8066560) was significantly associated with fasting 
LDL-cholesterol.
Figure 2 illustrates how n-3 PUFA intake modifies the association between rs11190480 in 
SCD and fasting cholesterol. Specifically, n-3 PUFA intake is positively associated with 
fasting cholesterol levels among all rs11190480 genotypes and this association is 
significantly attenuated among participants carrying both copies of the rs11190480 major 
allele (A/A). The mean δ15N by rs11190480 genotype are as follows: A/A—9.0‰ (95% CI: 
9.0, 9.1), A/G—9.0‰ (95% CI: 8.9, 9.2), G/G—9.1‰ (95% CI: 8.6, 9.7). We did not detect 
any significant interactions between SNPs in SLC2A4 and SREBF1 and n-3 PUFA intake 
with lipid/lipoprotein phenotypes.
3.5 ANALYSIS OF ANTHROPOMETRIC VARIABLES
We did not detect significant associations between SCD or SREBF1 polymorphisms and 
anthropometric variables upon adjusting for multiple testing (Figure 3). However, three 
polymorphisms (rs2654185, rs5415 and rs5417) in SLC2A4 were positively correlated with 
hip circumference and the rs2654185 locus was also positively associated with thigh 
circumference. Figure 4a shows that n-3 PUFA intake is positively correlated with waist-to-
hip ratio (WHR) among all rs599961 genotypes and this association is attenuated among 
individuals carrying at least one copy of the minor rs599961 allele (T/G and G/G). Similarly, 
Figure 4b shows that n-3 PUFA intake was positively correlated with WHR ratio among all 
rs7849 genotypes and this association was significantly attenuated among heterozygous 
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individuals (T/C). We did not detect significant interactions between SNPs in SLC2A4 or 
SREBF1 and n-3 PUFA intake on anthropometric variables.
3.6 ANALYSIS OF TYPE-2 DIABETES-RELATED PHENOTYPES
We did not detect SCD or SLCA24 polymorphisms significantly associated with T2D-
related phenotypes upon adjustment for multiple testing (Figure 5). Importantly, we 
observed a SREBF1 SNP (rs2297508) that was significantly associated with HOMA-IR and 
detected a significant interaction between n-3 PUFA intake and rs2282180 in SREBF1 on 
HOMA-IR. Figure 6 shows the positive correlation between n-3 PUFA intake and HOMA-
IR is notably stronger in those with at least one copy of the rs2282180 minor allele (G/A and 
A/A). We did not detect significant interactions between SNPs in SCD and SLC2A4 and n-3 
PUFA intake on T2DM-related phenotypes.
4 DISCUSSIONS
Our primary findings in a cross-sectional sample of Yup’ik people demonstrate genetic 
variations in SCD, SLC2A4, and SREBF1 were associated with fasting lipid/lipoprotein 
phenotypes and a traditional dietary pattern rich in n-3 PUFA intake modified the association 
between SCD and SREBF1 polymorphisms with anthropometric variables, circulating lipid/
lipoprotein and T2DM-related phenotypes. People adhering to a traditional Yup’ik dietary 
pattern rich in marine mammals and fish have consume n-3 polyunsaturated fatty acids 
(PUFAs), eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) at levels up to 20 
times higher than in the general US population [8, 52]. Using the nitrogen stable isotope 
ratio (d15N) as a validated, objective measure of the traditional dietary pattern, we have 
shown that high levels of traditional food intake are associated with high adiponectin and a 
low leptin:adiponectin ratio, suggestive of increased insulin sensitivity [8]. Published 
findings have shown that the transition away from the Yup'ik diet is associated with an 
increase in the prevalence of overweight and obesity, and that the prevalence of overweight 
and obesity in the population now mirrors that of the general U.S. population [11, 53]. At the 
same time, however, the prevalence of metabolic syndrome (15%)[43] and T2D (3%) among 
Yup’ik people remains lower than in the U.S. general population [14, 15], suggesting that 
consumption of a traditional diet enriched with n-3 PUFAs may contribute to “healthy 
obesity”. The results of this study extend what is known the traditional diet enriched inn-3 
PUFA and the “healthy obese” phenotype observed in Yup’ik people by demonstrating that 
the traditional diet rich in n-3 PUFAs is associated with anthropometric variables, circulating 
lipid/lipoprotein and T2DM-related phenotypes in Yup’ik people through gene-diet 
interactions with SCD, SLC2A4, and SREBF1 genotypes.
Previous studies that have examined SCD polymorphisms associated with obesity-related 
phenotypes have produced conflicting results [32, 36, 54]. Liew et al. failed to detect SCD 
polymorphisms associated with T2DM-related traits, BMI, or waist-hip-ratio in a large 
European case-control study [54]. Gong et al. reported that SCD genetic variation was 
positively associated with metabolic syndrome (MetS) in a Costa Rican cohort [32] and 
Rudkowska et al. reported that SCD genotypes in a Canadian cohort were associated with 
cardiometabolic risk factors alone or in combination with n-3 PUFA supplementation [40]. 
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In contrast, Warensjö et al. reported SCD polymorphisms were associated with increased 
insulin sensitivity, reduced BMI and smaller waist circumference in Swedish men [33]. Our 
analyses did not evaluate the contribution of SCD polymorphisms to T2DM status and MetS 
status directly, given the historically low prevalence of both T2DM (<3%) [11] and MetS 
(8.6 % in men and 19.8% in women) [43] observed among Yup’ik people. Nevertheless, we 
investigated the association between SCD polymorphisms with four of the five traits 
associated with MetS (FG, HDL-cholesterol, triglycerides and WC) as well as additional 
T2DM-related phenotypes and observed the minor allele of several SCD polymorphisms 
were nominally associated with a modest increase in FG (rs599961) and FG & HbA1c 
(rs599961 and rs7849). Collectively, our results are consistent with Warensjö et al., 
demonstrating that SCD genetic variation was associated with reduced adiposity and suggest 
that SCD activity may be an important mechanism that contributes to “healthy obesity” in 
this population.
More recently, the rs5435 minor allele in SLC2A4 was positively associated with T2DM and 
fasting insulin levels in a South Indian cohort [35] and the rs2654185 minor allele was 
positively associated with fasting HbA1c levels in a cohort of Japanese men [36]. Our results 
demonstrate the SLC2A4 rs2654185 polymorphism was significantly and positively 
associated with hip circumference (p=0.005) and thigh circumference (p=0.008). 
Additionally, we found the rs5435 minor allele, previously linked to risk of T2DM [35], was 
significantly associated with lower fasting HDL-cholesterol (p=0.006) and ApoA1 
concentrations (p=0.005). The rs5415 polymorphism in SLC2A4 was also inversely 
associated with fasting HDL-cholesterol (p=0.001) and ApoA1 levels (p=0.004) and 
positively associated with hip circumference (p=0.004). Taken together, we extend the 
findings of Bodhini et al. [35] and Xi et al. [36] by demonstrating SLC2A4 polymorphisms 
are associated with reduced fasting HDL-cholesterol levels and provide novel evidence that 
SLC2A4 is associated with anthropometric variables by increasing hip and thigh 
circumference.
In our study, we found the SREBF1 non-synonymous G952G (rs2297508) variant was 
significantly associated with elevated HOMA-IR levels (p=0.009) and nominally associated 
with elevated LDL-cholesterol levels (p=0.028) and fasting insulin levels (p=0.014). 
Consistent with these results, SREBF1 polymorphisms that were correlated with G952G 
(rs2297508) were associated with increased LDL-cholesterol (rs2282180: p=0.024 and 
rs8066560: p=0.012), elevated total cholesterol (rs8066560: p=0.031) and variation in 
fasting insulin levels (rs9899634: p=0.046, rs8066560: p=0.024 and rs9902941: p=0.027). 
Collectively, our results are consistent with the findings of Bouchard-Mercier et al. [41] by 
demonstrating that SREBF1 polymorphisms are associated with phenotypes that may impact 
insulin sensitivity, potentially through mechanisms that alter insulin secretion and increase 
lipid/lipoprotein synthesis.
Our previous work demonstrates that a traditional Yup’ik diet rich in n-3 PUFA intake is 
positively associated with total cholesterol, LDL, HDL and ApoA1 and inversely associated 
with TG in this study population having a 50-fold variation in consumption of EPA [8, 45]. 
Although n-3 PUFA supplementation is not always linked to a change in total plasma 
cholesterol levels [55], previous reports have demonstrated a significant decrease in total 
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cholesterol and a significant increase in HDL cholesterol after fish oil supplementation [56]. 
In this study, we found that SCD polymorphisms were positively associated with ApoA1 and 
that SCD genotypes attenuated the positive associations between the traditional dietary 
pattern and fasting cholesterol levels (Figure 2). Furthermore, the observed positive 
correlation between intake of the traditional diet and waist-to-hip ratio (WHR) was 
attenuated among individuals carrying the most common rs599961 (Figure 4a) and rs7849 
(Figure 4b) genotypes in SCD. An important observation made by our study demonstrates 
the positive correlation between intake of the traditional diet and HOMA-IR was attenuated 
among individuals carrying the dominant SREBF1 rs2282180 (G/G) (Figure 6). This result 
is supported by previous observations in a Canadian cohort that reported SREBF1 genetic 
variation mediates associations between fish oil supplementation and insulin sensitivity [41]. 
Collectively, our results suggest that relatively common genetic variants in SCD and 
SREBF1 (≥0.05 MAF) attenuated the positive associations between intake of a traditional 
diet rich in n-3 PUFAs and increases in fasting cholesterol and HbA1c levels, as well as the 
WHR among Yup’ik participants.
The strengths of this study include a Yup‘ik study population was ideally suited for 
investigations of the impact of n-3 PUFA [7, 9] and genetic factors [57, 58] on 
anthropometric variables, lipid/lipoprotein, and T2DM-related phenotypes given the 50-fold 
range of EPA consumption in this study population [45]. Our analyses also included a 
precise and objective measure of n-3 PUFA intake using nitrogen stable isotope ratios from 
red blood cells [59] and a sample size large enough to detect SNP associations and a 
statistical approach that accounts for familial relationships among participants [49]. 
Differences in results reported in the present study in comparison to other investigations may 
include, but are not limited to, small sample size, population stratification and differences in 
statistical analysis [60, 61]. The main limitation of this study was a cross-sectional 
experimental design that prevents the temporal order of exposures and outcomes to be 
determined and thus it is important to point out we are reporting only associations and 
causality is unclear. Additional limitations include potentially confounding factors (e.g. 
alcohol intake, exercise, nutrients enriched in the traditional diet in additional to n-3 PUFAs, 
and smoking status) that were not measured. Some of these factors have been shown to 
influence lipid, insulin and glucose metabolism.
In summary, the primary findings of this study demonstrate that polymorphisms within or 
near SCD, SLC2A4, SREBF1 are associated with anthropometric variables, lipid/
lipoprotein, and T2DM-related phenotypes in a study population with widely varying n-3 
PUFA intake. Moreover, our analyses revealed beneficial gene-diet interactions with SCD 
polymorphisms that attenuated the positive n-3 PUFA associations with fasting cholesterol 
levels and waist-to-hip ratio among individuals carrying the most common genotypes at 
those loci. Consistent with these results, we also found that n-3 PUFA intake attenuated the 
positive associations between SREBF1 polymorphisms with fasting HOMA-IR among 
individuals carrying the dominant rs2282180 genotype. Taken together, these results support 
our hypothesis that interactions between common SCD, SLC2A4, and SREBF1 genotypes 
and n-3 PUFA intake are associated with cardiometabolic phenotypes consistent with 
“healthy obesity”. Additional comprehensive genomic studies in longitudinal cohorts of 
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diverse populations having variable intake of n-3 PUFAs will be necessary to replicate these 
findings and determine the generalizability and public health implications of our findings.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. SCD, SLC2A4 and SREBF1 polymorphisms that are associated with lipid/lipoprotein 
phenotypes
Association of SNPs in a linear model adjusted for age, sex, lipid/lipoprotein medications, 
community membership, BMI, and n-3 PUFA intake. The solid red line represents statistical 
significance according to multiple test correction for each gene, estimated using the spectral 
decomposition of LD matrix [51]. The dotted red line represents nominal significance (p
−640.05). Total cholesterol (Chol), high-density lipoprotein (HDL), apolipoprotein A1 
(ApoA1), low-density lipoprotein (LDL), very-low density lipoprotein (VLDL) and 
triglycerides (TG).
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Figure 2. n-3 PUFA intake (δ1515N) modifies a SCD SNP associated with fasting cholesterol 
levels (rs11190480: p=0.007)
n-3 PUFA intake was positively associated (p=0.007) with fasting cholesterol levels among 
all rs11190480 genotypes and this association was significantly attenuated among 
participants carrying both copies of the rs11190480 major allele (A/A). Gene-diet 
interaction between continuous n-3 PUFA intake (δ15N) and categorical rs11190480 
genotypes were adjusted for participant age, sex, lipid medications, community membership, 
BMI, and n-3 PUFA intake. The figure legend notes the SNP [major>minor] allele, the 
sample size, beta and p-value for each genotype stratification.
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Figure 3. SCD, SLC2A4 and SREBF1 polymorphisms that are associated with anthropometric 
variables
Association of SNPs in a linear model adjusted for age, sex, community membership, and 
n-3 PUFA intake. The solid red line represents statistical significance according to multiple 
test correction for each gene, estimated using the spectral decomposition of LD matrix [51]. 
The dotted red line represents nominal significance (p≤0.05). Body mass index (BMI), 
percent body fat (PBF), hip circumference (HC), thigh circumference (ThC), waist 
circumference (WC), and waist-to-hip ratio (WHR).
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Figure 4. n-3 PUFA intake (δ15N) modifies SCD SNPs associated with waist-to-hip ratio 
(rs599961:p=0.006 and rs7849:p=0.007)
(A) n-3 PUFA intake is positively correlated with waist-to-hip ratio (WHR) among all 
rs599961 genotypes and this association is attenuated among individuals carrying at least 
one copy of the minor rs599961 allele (T/G and G/G). (B) n-3 PUFA intake was positively 
correlated with WHR ratio among all rs7849 genotypes and this association was 
significantly attenuated among heterozygous individuals (T/C). Gene-diet interaction 
between continuous n-3 PUFA intake (δ15N) and categorical SCD SNP (rs599961 and 
rs7849) genotypes were adjusted for participant age, sex, lipid medications, community 
membership, BMI, and n-3 PUFA intake. The figure legend notes the SNP [major>minor] 
allele, the sample size, beta and p-value for each genotype stratification.
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Figure 5. SCD, SLC2A4 and SREBF1 polymorphisms that are associated with type-2 diabetes 
mellitus related phenotypes
Association of SNPs in a linear model adjusted for age, sex, diabetes medications, 
community membership, BMI and n-3 PUFA intake. The solid red line represents statistical 
significance according to multiple test correction for each gene, estimated using the spectral 
decomposition of LD matrix [51]. The dotted red line represents nominal significance 
(p≤0.05). Fasting blood glucose (FG), glycosylated hemoglobin (HbA1c), homeostatic 
model assessment of beta-cell function (HOMA-B), homeostatic model assessment of 
insulin resistance (HOMA-IR), fasting insulin (FI), and fasting blood glucose & 
glycosylated hemoglobin (FG & HbA1c). (*) denotes SNPs that were analyzed using a 
dominant model of inheritance.
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Figure 6. n-3 PUFA intake (δ15N) modifies SREBF1 SNP association with HOMA-IR 
(rs2282180*: p=0.002)
The positive association between n-3 PUFA intake and HOMA-IR is attenuated among 
individuals carrying two copies of the rs2282180 major allele (G/G). Gene-diet interaction 
between continuous n-3 PUFA intake (δ15N) and categorical rs2282180 genotypes were 
adjusted for participant age, sex, community membership, BMI, and n-3 PUFA intake. The 
figure legend notes the SNP [major>minor] allele, the sample size, beta and p-value for each 
genotype stratification. (*) denotes that SNP was analyzed using dominant model of 
inheritance.
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Table 1
Descriptive statistics of Yup'ik participantsa,b
Variables Women Men p-values
No. of participants 597 538
Age (yrs) 40.5 (38.1 - 42.6) 38.8 (37.8 - 39.8) 0.1271
Anthropometric Variables
BMI (kg/m2) 28.9 (28.1 - 29.8) 26.4 (26.0 - 26.8) <0.0001
Percentage Body Fat (%) 43.1 (41.8 - 44.4) 28.0 (27.4 - 28.6) <0.0001
Waist Circumference (cm) 88.4 (86.5 - 90.4) 87.8 (86.8 - 88.8) 0.4456
Hip Circumference (cm) 105.8 (104.3 - 107.4) 98.9 (98.2 - 98.7) <0.0001
Thigh Circumference (cm) 51.2 (50.5 - 51.9) 50.4 (50.0 - 50.8) 0.0101
Waist-to-Hip Ratio 0.86 (0.86 – 0.87) 0.92 (0.91 – 0.92) <0.0001
Lipid/lipoprotein Measures
Cholesterol (mg/dL) 215.4 (209.1 - 221.9) 205.8 (202.6 - 209.1) <0.0001
HDL (mg/dL) 66.2 (63.8 - 68.8) 56.8 (55.7 - 58.0) <0.0001
Apolipoprotein A-I (mg/dL) 175.9 (172.1 - 179.9) 162.9 (168.0 - 165.0) <0.0001
LDL (mg/dL) 130.2 (125.2 - 135.3) 130 (127.2 - 132.8) 0.9090
VLDL (mg/dL) 15.2 (14.3 - 16.1) 15.2 (14.7 - 15.7) 0.9720
Triglyceride (mg/dL) 75.6 (71.4 - 80.1) 74.3 (71.9 - 76.9) 0.5029
Diabetes-Related Measures
Fasting glucose (mg/dL) 90.2 (88.9 -91.6) 92.2 (91.5 - 93.0) 0.0007
HbA1c (%) 5.36 (5.31 - 5.41) 5.42 (5.40 - 5.45) 0.0049
HOMA-B 232.6 (215.5 - 249.6) 189.2 (180.9 - 197.5) <0.0001
HOMA-IR 3.9 (3.5 - 4.2) 3.4 (3.3 - 3.6) 0.0049
Fasting insulin (μU/ml) 15.3 (14.3 - 16.3) 13.4 (13.0 - 14.0) <0.0001
aValues are reported as mean (95% CI) predicted from linear model accounting for familial correlations among 195 pedigrees with a mean pedigree 
size of 5.82 individuals (range, 1-893).
bp-values for differences by gender are derived using student t-test.
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Table 2
Distribution of the RBC nitrogen stable isotope ratio (δ15N) in Yup'ik peoplea,b Total Women Men
Total Women Men
No. of participants 1135 597 538
Mean ± SD (‰) 9.0 ± 1.5 9.1 ± 1.5 8.8 ± 1.5
Maximum 15.2 15.2 13.5
Minimum 6.2 6.4 6.2
Range (‰) 9 8.8 7.3
a
Isotope ratios are presented as delta values in “permil” relative to atmospheric nitrogen: δ15N = [(15N/14Nsample - 15N/14Nstandard)/
( 15N/14Nstandard)] · 1000‰.
b
The relationship between δ15N and EPA follows the linear model: EPA (%RBC fatty acid) =1.04 · δ15N - 6.7‰, as previously described for this 
population [45].
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